{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:19:26Z","timestamp":1793848766404,"version":"4.6.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.clinbiochem.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:06:06Z","timestamp":1671188766000},"page":"6-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use"],"prefix":"10.1016","volume":"112","author":[{"given":"Ibrahim","family":"Choucair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Figueroa","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-7080","authenticated-orcid":false,"given":"Michael A.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Cassella-Mclane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1107-8148","authenticated-orcid":false,"given":"Thomas J.S.","family":"Durant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-9540","authenticated-orcid":false,"given":"Joe M.","family":"El-Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.clinbiochem.2022.12.009_b0005","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1001\/jama.2017.10910","article-title":"Interpretation of urine drug screens: metabolites and impurities","volume":"318","author":"Nagpal","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.clinbiochem.2022.12.009_b0010","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1373\/clinchem.2017.283507","article-title":"The missing metabolite: how unexpected urine drug metabolite patterns may lead to false interpretations","volume":"64","author":"Hutcherson Wright","year":"2018","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.12.009_b0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/clinchem\/hvaa319","article-title":"Commentary on unexpected presence of an unusual opioid in a patient with chronic pain","volume":"67","author":"Jannetto","year":"2021","journal-title":"Clin. Chem."},{"issue":"2 Suppl","key":"10.1016\/j.clinbiochem.2022.12.009_b0020","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.36076\/ppj.2008\/11\/S155","article-title":"Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility","volume":"11","author":"Manchikanti","year":"2008","journal-title":"Pain Phys."},{"key":"10.1016\/j.clinbiochem.2022.12.009_b0025","unstructured":"Mandatory guidelines for federal workplace drug testing programs. Department of Health and Human Services., in: D.O.H.A.H. SERVICES (Ed.) 2017."},{"issue":"4","key":"10.1016\/j.clinbiochem.2022.12.009_b0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: American Association of clinical chemistry laboratory medicine practice guideline-using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J. Appl. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2022.12.009_b0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/FTD.0b013e3181c1082a","article-title":"Anomalous observations of codeine in patients on morphine","volume":"31","author":"West","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2022.12.009_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2010.08.029","article-title":"Anomalous observations of hydrocodone in patients on oxycodone","volume":"412","author":"West","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.clinbiochem.2022.12.009_b0045","unstructured":"Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, Rockville (MD), 2006."},{"issue":"7","key":"10.1016\/j.clinbiochem.2022.12.009_b0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jat\/bks058","article-title":"Excretion profile of hydrocodone, hydromorphone and norhydrocodone in urine following single dose administration of hydrocodone to healthy volunteers","volume":"36","author":"Valtier","year":"2012","journal-title":"J. Anal. Toxicol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202200279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202200279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:58:41Z","timestamp":1757865521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202200279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":10,"alternative-id":["S000991202200279X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.12.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preliminary study of hydrocodone and hydromorphone to oxycodone ratios for distinguishing impurities from independent opioid use","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}